Business Description
Acticor Biotech SA
ISIN : FR0014005OJ5
Compare
Compare
Traded in other countries / regions
ALACT.France7V7.Germany IPO Date
2021-11-01Description
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.66 | |||||
| Equity-to-Asset | -0.55 | |||||
| Debt-to-Equity | -1.11 | |||||
| Debt-to-EBITDA | -0.4 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -23.1 | |||||
| 3-Year EPS without NRI Growth Rate | -30.9 | |||||
| 3-Year FCF Growth Rate | -18.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.97 | |||||
| 9-Day RSI | 37.1 | |||||
| 14-Day RSI | 41.17 | |||||
| 6-1 Month Momentum % | -48.75 | |||||
| 12-1 Month Momentum % | -88.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.98 | |||||
| Quick Ratio | 0.98 | |||||
| Cash Ratio | 0.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.6 | |||||
| Shareholder Yield % | -215.19 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -128.76 | |||||
| ROIC % | -574.04 | |||||
| ROC (Joel Greenblatt) % | -72885.94 | |||||
| ROCE % | -380.61 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 0.19 | |||||
| EV-to-EBIT | -0.41 | |||||
| EV-to-EBITDA | -0.43 | |||||
| EV-to-FCF | -0.56 | |||||
| Earnings Yield (Greenblatt) % | -241.65 | |||||
| FCF Yield % | -296 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Acticor Biotech SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.13 | ||
| Beta | -0.08 | ||
| Volatility % | 165.86 | ||
| 14-Day RSI | 41.17 | ||
| 14-Day ATR (€) | 0.061444 | ||
| 20-Day SMA (€) | 0.36325 | ||
| 12-1 Month Momentum % | -88.86 | ||
| 52-Week Range (€) | 0.22 - 5.32 | ||
| Shares Outstanding (Mil) | 15.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Acticor Biotech SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Acticor Biotech SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Acticor Biotech SA Frequently Asked Questions
What is Acticor Biotech SA(XPAR:ALACT)'s stock price today?
The current price of XPAR:ALACT is €0.28. The 52 week high of XPAR:ALACT is €5.32 and 52 week low is €0.22.
When is next earnings date of Acticor Biotech SA(XPAR:ALACT)?
The next earnings date of Acticor Biotech SA(XPAR:ALACT) is .
Does Acticor Biotech SA(XPAR:ALACT) pay dividends? If so, how much?
Acticor Biotech SA(XPAR:ALACT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers